cns diseases1

Upload: deepthi-talasila

Post on 07-Apr-2018

225 views

Category:

Documents


0 download

TRANSCRIPT

  • 8/6/2019 cns diseases1

    1/304

    11/07/11 MUN FP Academic Half Day 1

    Definition Of Stroke

    Rapidly developed clinical sign offocal disturbance of cerebral functionof presumed vascular origin and ofmore than 24 hours WHO

    TIA (Transient Ischemic Attack)recovery is complete within 24

    hours. 10% of patients will go on tohave a stroke.

  • 8/6/2019 cns diseases1

    2/304

    11/07/11 MUN FP Academic Half Day 2

    Sub-types Of Stroke

    Ischemic obstruction to one ofmajor cerebral arteries, brainstemstrokes are less common.

    Haemorrhage 9% are caused byhaemorrhage to the deep parts ofthe brain. Patients are usually

    hypertensive.

  • 8/6/2019 cns diseases1

    3/304

    11/07/11 MUN FP Academic Half Day 3

    Common Causes

    Thrombosis Lacunar stroke (small vessel)

    Large vessel thrombosis

    Dehydration

  • 8/6/2019 cns diseases1

    4/304

    11/07/11 MUN FP Academic Half Day 4

    Causes of Ischemic Stroke

    Embolic occlusion

    Artery-to-artery

    Carotid bifurcation

    Aortic arch

    Arterial dissection

  • 8/6/2019 cns diseases1

    5/304

    11/07/11 MUN FP Academic Half Day 5

    Cardio embolic

    causes of Ischemic Stroke

    Atrial fibrillation

    Mural thrombus

    Myocardial infarction

    Dilated cardiomyopathy

    Valvular lesions

    Mitral stenosis

    Mechanical valveBacterial endocarditis

  • 8/6/2019 cns diseases1

    6/304

    11/07/11 MUN FP Academic Half Day 6

    Causes of Ischemic Stroke

    Paradoxical embolus

    Atrial septal defect

    Patent foramen ovaleAtrial septal aneurysm

    Spontaneous echo contrast

  • 8/6/2019 cns diseases1

    7/304

    11/07/11 MUN FP Academic Half Day 7

    Uncommon Causes

    Hypercoaguable disordersProtein C deficiency

    Protein S deficiency

    Antithrombin III deficiency

    Antiphospholipid syndrome

    Factor V Leiden mutationa

    Prothrombin G20210 mutationaSystemic malignancy

  • 8/6/2019 cns diseases1

    8/304

    11/07/11 MUN FP Academic Half Day 8

    Uncommon Causes

    Sickle cell anemia

    -Thalassemia

    Polycythemia vera

    Systemic lupus erythematosus

    Homocysteinemia Thrombotic thrombocytopenic purpura

    Disseminated intravascular coagulation

    Dysproteinemias

    Nephrotic syndrome

    Inflammatory bowel disease Oral contraceptives

  • 8/6/2019 cns diseases1

    9/304

    11/07/11 MUN FP Academic Half Day 9

    Uncommon Causes

    Venous sinuous thrombosis

    Fibro muscular dysplasia

    Vasculitis Systemic vasculitis (PAN, Wegener's,

    Takayasu's, giant cell arteritis)

    Primary CNS vasculitis

    Meningitis (syphilis, tuberculosis,

    fungal, bacterial, zoster)

  • 8/6/2019 cns diseases1

    10/304

    11/07/11 MUN FP Academic Half Day 10

    Uncommon Causes

    CardiogenicMitral valve calcificationAtrial myxoma Intracardiac tumorMarantic endocarditis Libman-Sacks endocarditis

    Subarachnoid hemorrhage vasospasmDrugs: cocaine, amphetamine

    Moyamoya disease Eclampsia

  • 8/6/2019 cns diseases1

    11/304

    11/07/11 MUN FP Academic Half Day 11

    Fibro muscular dysplasia

    Affects the cervical arteries andoccurs mainly in women.

    The carotid or vertebral arteries showmultiple rings of segmentalnarrowing alternating with dilatation.

    Occlusion is usually incomplete. The process is often asymptomatic

    but occasionally is associated with an

    audible bruit, TIAs, or stroke. Involvement of the renal arteries iscommon and may result inhypertension.

  • 8/6/2019 cns diseases1

    12/304

    11/07/11 MUN FP Academic Half Day 12

    Moyamoya disease

    Occlusive disease

    Large intracranial arteries, especially thedistal internal carotid artery and the stemof the MCA and ACA

    Vascular inflammation is absent.

    "Puff of smoke" (moyamoya in Japanese)on conventional x-ray angiography.

  • 8/6/2019 cns diseases1

    13/304

    11/07/11 MUN FP Academic Half Day 13

    "Puff of smoke" (moyamoya in

    Japanese)

    The lenticulostriate arteries developa rich collateral circulation aroundthe occlusive lesion, which gives the

    impression of a "Puff of smoke"(Moyamoya in Japanese)

    Other collaterals include

    Transdural anastomoses betweenthe cortical surface branches of themeningeal and scalp arteries.

  • 8/6/2019 cns diseases1

    14/304

    11/07/11 MUN FP Academic Half Day 14

    AVMs

    AVMs occur in all parts of the cerebralhemispheres, brainstem, and spinalcord,

    Largest ones are most frequently inthe posterior half of the hemispheres,commonly forming a wedge-shapedlesion extending from the cortex to

    the ventricle. Present from birth in most patients,

  • 8/6/2019 cns diseases1

    15/304

    11/07/11 MUN FP Academic Half Day 15

    Bleeding or other symptoms

    Most common between the ages

    of 10 and 30, occasionally aslate as the fifties.

    AVMs are more frequent in men,and rare familial cases have

    been described.

  • 8/6/2019 cns diseases1

    16/304

    11/07/11 MUN FP Academic Half Day 16

    AVMs

    Headache (without bleeding) may behemicranial and throbbing, like migraine, ordiffuse.

    Focal seizures, with or without

    generalization, occur in ~30% of cases. Half of AVMs become evident asintracerebral hemorrhages.

    In most, the hemorrhage is mainlyintraparenchymal with extension into thesubarachnoid space in some cases.

  • 8/6/2019 cns diseases1

    17/304

    11/07/11 MUN FP Academic Half Day 17

    AVMs complications

    The risk of rerupture is ~24%per year and is particular high inthe first few weeks.

    Hemorrhages may be massive,leading to death, or may be assmall as 1 cm in diameter,

    leading to minor focalsymptoms or no deficit.

  • 8/6/2019 cns diseases1

    18/304

    11/07/11 MUN FP Academic Half Day 18

    steal blood

    The AVM may be large enough tosteal blood away from adjacentnormal brain tissue or to increase

    venous pressure significantly toproduce venous ischemia locally andin remote areas of the brain.

    This is seen most often with large

    AVMs in the territory of the MCA.

  • 8/6/2019 cns diseases1

    19/304

    11/07/11 MUN FP Academic Half Day 19

    Large AVMs of the anterior

    circulation

    Systolic and diastolic bruit(sometimes self-audible) overthe eye, forehead, or neck

    Bounding carotid pulse.

  • 8/6/2019 cns diseases1

    20/304

    11/07/11 MUN FP Academic Half Day 20

    Silent

    Headache at the onset of AVMrupture is not generally asexplosive as with aneurysmalrupture.

  • 8/6/2019 cns diseases1

    21/304

    11/07/11 MUN FP Academic Half Day 21

    Imageology

    MRI is better than CT fordiagnosis, although noncontrastCT scanning sometimes detectscalcification of the AVM andcontrast may demonstrate theabnormal blood vessels.

  • 8/6/2019 cns diseases1

    22/304

    11/07/11 MUN FP Academic Half Day 22

    Future

    The impact of recurrenthemorrhage on disability isrelatively modest, so the

    indication for Surgery in asymptomatic AVMs

    is debated A large-scale randomized trial is

    currently addressing thisquestion.

  • 8/6/2019 cns diseases1

    23/304

    11/07/11 MUN FP Academic Half Day 23

  • 8/6/2019 cns diseases1

    24/304

    11/07/11 MUN FP Academic Half Day 24

  • 8/6/2019 cns diseases1

    25/304

    11/07/11 MUN FP Academic Half Day 25

  • 8/6/2019 cns diseases1

    26/304

    11/07/11 MUN FP Academic Half Day 26

  • 8/6/2019 cns diseases1

    27/304

    11/07/11 MUN FP Academic Half Day 27

  • 8/6/2019 cns diseases1

    28/304

    11/07/11 MUN FP Academic Half Day 28

  • 8/6/2019 cns diseases1

    29/304

    11/07/11 MUN FP Academic Half Day 29

  • 8/6/2019 cns diseases1

    30/304

    11/07/11 MUN FP Academic Half Day 30

  • 8/6/2019 cns diseases1

    31/304

    11/07/11 MUN FP Academic Half Day 31

    FIGURE 3.11. Non-contrast brain CTscan showing massive intraventricu-lar haemorrhage withhydrocephalus as well aswidespread subarachnoidhaemorrhage. The patient was aged

    45 years and suddenly slumped ontop of his wife during intercourse.

  • 8/6/2019 cns diseases1

    32/304

    11/07/11 MUN FP Academic Half Day 32

  • 8/6/2019 cns diseases1

    33/304

    11/07/11 MUN FP Academic Half Day 33

    FIGURE 3.15. Digital subtractionangiogram showing a left middlecerebral artery aneurysm (arrow).

  • 8/6/2019 cns diseases1

    34/304

    11/07/11 MUN FP Academic Half Day 34

  • 8/6/2019 cns diseases1

    35/304

    11/07/11 MUN FP Academic Half Day 35

    CT scan of a 31-year-old male withsud- den right hemiplegia andaltered level of consciousness,showing a large left basalganglia/internal capsularhaemorrhage. Note the movement

    artefacts as the patient was restlessand not fully co-operative.

  • 8/6/2019 cns diseases1

    36/304

    11/07/11 MUN FP Academic Half Day 36

  • 8/6/2019 cns diseases1

    37/304

    11/07/11 MUN FP Academic Half Day 37

    Medial

    PMB of upper basilar andproximal Posterior CerebralArtery

    PMB of UBA

    PMB of MBA

    PMB of basilar artery

    Occlusion of VA or of branch ofvertebral or LBA

  • 8/6/2019 cns diseases1

    38/304

    11/07/11 MUN FP Academic Half Day 38

    Lateral

    Small penetrating arteries arisingfrom PCA

    Syndrome of superior Cerebellar

    artery SCFA (short circumferential artery)

    AICA

    PICA, Superior, middle, or inferiorbranches of lateral medullary artery,vertebral artery

  • 8/6/2019 cns diseases1

    39/304

    11/07/11 MUN FP Academic Half Day 39

    Midbrain syndrome:

    Medial

    Paramedian branches of upper

    basilar and proximal posteriorcerebral arteries

    Lateral

    Syndrome of small penetratingarteries arising from posteriorcerebral artery

  • 8/6/2019 cns diseases1

    40/304

    11/07/11 MUN FP Academic Half Day 40

    Superior pontine syndrome

    Medial (paramedian branches ofupper basilar artery)

    Lateral (syndrome of superiorCerebellar artery)

  • 8/6/2019 cns diseases1

    41/304

    11/07/11 MUN FP Academic Half Day 41

    Middle pontine syndrome

    Medial midpontine syndrome(paramedian branch ofmidbasilar artery)

    Lateral midpontine syndrome(short circumferential artery)

  • 8/6/2019 cns diseases1

    42/304

    11/07/11 MUN FP Academic Half Day 42

    Inferior pontine syndrome

    Medial (occlusion of paramedianbranch of basilar artery)

    Lateral (occlusion of anteriorinferior Cerebellar artery)

  • 8/6/2019 cns diseases1

    43/304

    11/07/11 MUN FP Academic Half Day 43

    Medullary syndrome

    Medial (occlusion of vertebralartery or of branch of vertebralor lower basilar artery)

    Lateral (occlusion of any of fivevessels may be responsiblevertebral, posterior inferiorCerebellar, superior, middle, or

    inferior lateral medullaryarteries)

  • 8/6/2019 cns diseases1

    44/304

    11/07/11 MUN FP Academic Half Day 44

    IPSILATERAL

    Medial midbrain syndrome(paramedian branches of upperbasilar and proximal posterior

    cerebral arteries) Eye "down and out" secondary

    to unopposed action of fourthand sixth cranial nerves, with

    dilated and unresponsive pupil:Third nerve fibers

  • 8/6/2019 cns diseases1

    45/304

    11/07/11 MUN FP Academic Half Day 45

    Lateral midbrain syndrome

    Lateral midbrain syndrome (syndrome ofsmall penetrating arteries arising fromposterior cerebral artery)

    Eye "down and out" secondary to unopposed

    action of fourth and sixth cranial nerves,with dilated and unresponsive pupil: Thirdnerve fibers and/or third nerve nucleus

    On side opposite lesion Hemiataxia, hyperkinesias, tremor: Red

    nucleus, dentatorubrothalamic pathway

  • 8/6/2019 cns diseases1

    46/304

    11/07/11 MUN FP Academic Half Day 46

    IPSILATERAL (medial syndromes)

    Medial midbrain syndrome(paramedian branches of upperbasilar and proximal posterior

    cerebral arteries) Eye "down and out" secondary

    to unopposed action of fourthand sixth cranial nerves, with

    dilated and unresponsive pupil:Third nerve fibers

  • 8/6/2019 cns diseases1

    47/304

    11/07/11 MUN FP Academic Half Day 47

    IPSILATERAL (medial syndromes)

    Medial superior pontine syndrome(paramedian branches of upper basilarartery)

    Cerebellar ataxia (probably): Superior

    and/or middle Cerebellar peduncle Internuclear ophthalmoplegia: Medial

    longitudinal fasciculus Myoclonic syndrome, palate, pharynx, vocal

    cords, respiratory apparatus, face,

    oculomotor apparatus, etc.: Localizationuncertaincentral tegmental bundle,dentate projection, inferior olivary nucleus

  • 8/6/2019 cns diseases1

    48/304

    11/07/11 MUN FP Academic Half Day 48

    IPSILATERAL (medial syndromes)

    Medial midpontine syndrome(paramedian branch ofmidbasilar artery)

    Ataxia of limbs and gait (moreprominent in bilateralinvolvement): Pontine nuclei

  • 8/6/2019 cns diseases1

    49/304

    11/07/11 MUN FP Academic Half Day 49

    IPSILATERAL (medial syndromes)

    Medial inferior pontine syndrome(occlusion of paramedian branch ofbasilar artery)

    Paralysis of conjugate gaze to side of

    lesion (preservation of convergence):Center for conjugate lateral gaze

    Nystagmus: Vestibular nucleus Ataxia of limbs and gait: Likely

    middle Cerebellar peduncle Diplopia on lateral gaze:Abducens

    nerve

  • 8/6/2019 cns diseases1

    50/304

    11/07/11 MUN FP Academic Half Day 50

    IPSILATERAL (medial syndromes)

    Medial medullary syndrome(occlusion of vertebral artery orof branch of vertebral or lower

    basilar artery) Paralysis with atrophy of half

    the tongue:Ipsilateral twelfth

    nerve

  • 8/6/2019 cns diseases1

    51/304

    11/07/11 MUN FP Academic Half Day 51

    IPSILATERAL (lateral syndromes)

    Lateral midbrain syndrome (syndrome ofsmall penetrating arteries arising fromposterior cerebral artery)

    Eye "down and out" secondary to unopposed

    action of fourth and sixth cranial nerves,with dilated and unresponsive pupil: Thirdnerve fibers and/or third nerve nucleus

    On side opposite lesion Hemiataxia, hyperkinesias, tremor: Red

    nucleus, dentatorubrothalamic pathway

  • 8/6/2019 cns diseases1

    52/304

    11/07/11 MUN FP Academic Half Day 52

    IPSILATERAL (lateral syndromes)

    Lateral superior pontine syndrome(syndrome of superior Cerebellarartery)

    Ataxia of limbs and gait, falling toside of lesion: Middle and superiorCerebellar peduncles, superior

    surface of cerebellum, dentatenucleus

    Dizziness, nausea, vomiting;horizontal nystagmus: Vestibularnucleus

    Lateral superior pontine syndrome

  • 8/6/2019 cns diseases1

    53/304

    11/07/11 MUN FP Academic Half Day 53

    Lateral superior pontine syndrome

    (syndrome of superior Cerebellar artery)

    Paresis of conjugate gaze(ipsilateral): Pontine contralateral

    gaze Skew deviation: Uncertain Miosis, ptosis, decreased sweating

    over face (Horner's syndrome):Descending sympathetic fibers

    Tremor: Localization unclearDentate nucleus, superior cerebellarpeduncle

  • 8/6/2019 cns diseases1

    54/304

    11/07/11 MUN FP Academic Half Day 54

    IPSILATERAL (lateral syndromes)

    Lateral midpontine syndrome (shortcircumferential artery)

    Ataxia of limbs: Middle Cerebellar

    peduncle Paralysis of muscles of mastication:

    Motor fibers or nucleus of fifth nerve

    Impaired sensation over side of face:

    Sensory fibers or nucleus of fifthnerve

  • 8/6/2019 cns diseases1

    55/304

    11/07/11 MUN FP Academic Half Day 55

    IPSILATERAL (lateral syndromes)

    Lateral inferior pontinesyndrome (occlusion of anteriorinferior Cerebellar artery)

    Horizontal and verticalnystagmus, vertigo, nausea,vomiting, oscillopsia: Vestibular

    nerve or nucleus Facial paralysis: Seventh nerve

    Lateral inferior pontine syndrome (occlusion of

  • 8/6/2019 cns diseases1

    56/304

    11/07/11 MUN FP Academic Half Day 56

    Lateral inferior pontine syndrome (occlusion of

    anterior inferior Cerebellar artery)

    Paralysis of conjugate gaze to side oflesion: Center for conjugate lateral

    gaze Deafness, tinnitus:Auditory nerve or

    cochlear nucleus Ataxia: Middle Cerebellar peduncle

    and Cerebellar hemisphere Impaired sensation over face:

    Descending tract and nucleus fifthnerve

  • 8/6/2019 cns diseases1

    57/304

    11/07/11 MUN FP Academic Half Day 57

    IPSILATERAL (lateral syndromes)

    Lateral medullary syndrome(occlusion of any of five vessels maybe responsiblevertebral, posterior

    inferior Cerebellar, superior, middle,or inferior lateral medullary arteries)

    Pain, numbness, impaired sensationover half the face: Descending tract

    and nucleus fifth nerve

  • 8/6/2019 cns diseases1

    58/304

    11/07/11 MUN FP Academic Half Day 58

    LMS

    Ataxia of limbs, falling to side oflesion: Uncertainrestiform body,Cerebellar hemisphere, Cerebellar

    fibers, spinocerebellar tract (?) Nystagmus, diplopia, oscillopsia,

    vertigo, nausea, vomiting:

    Vestibular nucleus

  • 8/6/2019 cns diseases1

    59/304

    11/07/11 MUN FP Academic Half Day 59

    LMS

    Horner's syndrome (miosis, ptosis,decreased sweating): Descending

    sympathetic tract

    Dysphagia, hoarseness, paralysis ofpalate, paralysis of vocal cord,diminished gag reflex:Issuing fibersninth and tenth nerves

    Loss of taste: Nucleus and tractussolitarius

  • 8/6/2019 cns diseases1

    60/304

    11/07/11 MUN FP Academic Half Day 60

    LMS

    Numbness of ipsilateral arm,trunk, or leg: Cuneate andgracile nuclei

    Weakness of lower face:Genuflected upper motor neuronfibers to ipsilateral facial

    nucleus

  • 8/6/2019 cns diseases1

    61/304

    11/07/11 MUN FP Academic Half Day 61

    CONTRALATERAL (medial

    syndromes)

  • 8/6/2019 cns diseases1

    62/304

    11/07/11 MUN FP Academic Half Day 62

    CONTRALATERAL (medial

    syndromes)

    Medial midbrain syndrome(paramedian branches of upperbasilar and proximal posterior

    cerebral arteries) Paralysis of face, arm, and leg:

    Corticobulbar and corticospinal

    tract descending in crus cerebri

  • 8/6/2019 cns diseases1

    63/304

    11/07/11 MUN FP Academic Half Day 63

    CONTRALATERAL (medial

    syndromes)

    Medial superior pontine syndrome(paramedian branches of upperbasilar artery)

    Paralysis of face, arm, and leg:Corticobulbar and corticospinal tract

    Rarely touch, vibration, and positionare affected: Medial lemniscus

  • 8/6/2019 cns diseases1

    64/304

    11/07/11 MUN FP Academic Half Day 64

    CONTRALATERAL (medial

    syndromes)

    Medial midpontine syndrome(paramedian branch of midbasilarartery)

    Paralysis of face, arm, and leg:Corticobulbar and corticospinal tract

    Variable impaired touch andproprioception when lesion extends

    posteriorly: Medial lemniscus

    CO (

  • 8/6/2019 cns diseases1

    65/304

    11/07/11 MUN FP Academic Half Day 65

    CONTRALATERAL (medial

    syndromes)

    Medial inferior pontine syndrome(occlusion of paramedian branch ofbasilar artery)

    Paralysis of face, arm, and leg:Corticobulbar and corticospinal tractin lower Pons

    Impaired tactile and proprioceptive

    sense over half of the body: Mediallemniscus

    CONTRALATERAL ( di l

  • 8/6/2019 cns diseases1

    66/304

    11/07/11 MUN FP Academic Half Day 66

    CONTRALATERAL (medial

    syndromes)

    Medial medullary syndrome(occlusion of vertebral artery or ofbranch of vertebral or lower basilar

    artery) Paralysis of arm and leg, sparing

    face; impaired tactile andproprioceptive sense over half the

    body: Contralateral pyramidal tractand medial lemniscus

    CONTRALATERAL

  • 8/6/2019 cns diseases1

    67/304

    11/07/11 MUN FP Academic Half Day 67

    CONTRALATERAL

    (Lateral syndromes)

    Lateral midbrain syndrome(syndrome of small penetratingarteries arising from posterior

    cerebral artery) Hemiataxia, hyperkinesias,

    tremor: Red nucleus,

    dentatorubrothalamic pathway

    CONTRALATERAL

  • 8/6/2019 cns diseases1

    68/304

    11/07/11 MUN FP Academic Half Day 68

    CONTRALATERAL

    (Lateral syndromes)

    Lateral superior pontine syndrome(syndrome of superior Cerebellarartery)

    Impaired pain and thermal sense onface, limbs, and trunk: Spinothalamictract

    Impaired touch, vibration, andposition sense, more in leg than arm

    (there is a tendency to incongruity ofpain and touch deficits): Mediallemniscus (lateral portion)

    CONTRALATERAL

  • 8/6/2019 cns diseases1

    69/304

    11/07/11 MUN FP Academic Half Day 69

    CONTRALATERAL

    (Lateral syndromes)

    Lateral midpontine syndrome(short circumferential artery)

    Impaired pain and thermalsense on limbs and trunk:Spinothalamic tract

    CONTRALATERAL

  • 8/6/2019 cns diseases1

    70/304

    11/07/11 MUN FP Academic Half Day 70

    CONTRALATERAL

    (Lateral syndromes)

    Lateral inferior pontinesyndrome (occlusion of anteriorinferior Cerebellar artery)

    Impaired pain and thermalsense over half the body (mayinclude face): Spinothalamic

    tract

    CONTRALATERAL

  • 8/6/2019 cns diseases1

    71/304

    11/07/11 MUN FP Academic Half Day 71

    CONTRALATERAL

    (Lateral syndromes)

    Lateral medullary syndrome(occlusion of any of five vessels maybe responsiblevertebral, posterior

    inferior Cerebellar, superior, middle,or inferior lateral medullary arteries)

    Impaired pain and thermal senseover half the body, sometimes face:

    Spinothalamic tract

  • 8/6/2019 cns diseases1

    72/304

    11/07/11 MUN FP Academic Half Day 72

    Lateral midpontine syndrome:Impaired pain and thermal sense onlimbs and trunk: Spinothalamic tract

    Lateral inferior pontine syndrome

    :Impaired pain and thermal senseover half the body (may includeface): Spinothalamic tract

    Lateral medullary syndrome :Impaired pain and thermal sense

    over half the body, sometimes face:Spinothalamic tract

  • 8/6/2019 cns diseases1

    73/304

    11/07/11 MUN FP Academic Half Day 73

  • 8/6/2019 cns diseases1

    74/304

    11/07/11 MUN FP Academic Half Day 74

  • 8/6/2019 cns diseases1

    75/304

  • 8/6/2019 cns diseases1

    76/304

    11/07/11 MUN FP Academic Half Day 76

    Medial midbrain syndrome

    (paramedian branches of upperbasilar and proximal posteriorcerebral arteries)

    Eye "down and out" secondaryto unopposed action of fourthand sixth cranial nerves, with

    dilated and unresponsive pupil:Third nerve fibers

  • 8/6/2019 cns diseases1

    77/304

    11/07/11 MUN FP Academic Half Day 77

  • 8/6/2019 cns diseases1

    78/304

    11/07/11 MUN FP Academic Half Day 78

  • 8/6/2019 cns diseases1

    79/304

    11/07/11 MUN FP Academic Half Day 79

  • 8/6/2019 cns diseases1

    80/304

    11/07/11 MUN FP Academic Half Day 80

    Lacunar infarcts

  • 8/6/2019 cns diseases1

    81/304

    11/07/11 MUN FP Academic Half Day 81

    Lacunar infarcts

    Lacunar infarcts are small infarcts inthe deeper parts of the brain (basalganglia, thalamus, white matter)

    and in the brain stem. They are responsible for about 20

    percent of all strokes.

    Lacunar infarcts

  • 8/6/2019 cns diseases1

    82/304

    11/07/11 MUN FP Academic Half Day 82

    Lacunar infarcts

    Other names given to this pathologyare

    Small artery arteriosclerosis",

    Hyaline atreriolosclerosis",

    Lipohyalinosis".

  • 8/6/2019 cns diseases1

    83/304

    Lacunar infarcts

  • 8/6/2019 cns diseases1

    84/304

    11/07/11 MUN FP Academic Half Day 84

    Lacunar infarcts

    They are caused by occlusion of deeppenetrating branches of major cerebralarteries and are particularly common inhypertension and diabetes, which areassociated with severe atherosclerosis ofsmall vessels and small vessel disease

    A small lacunar infarct (e.g., one involvingthe internal capsule) can cause as severe aneurological deficit as can a much largerhemispheric infarct but without the life-

    threatening cerebral edema that is seen inthe latter.

  • 8/6/2019 cns diseases1

    85/304

    11/07/11 MUN FP Academic Half Day 85

    Embolic occlusion

    Artery-to-artery Carotid bifurcation

    Aortic arch

    Arterial dissection

    Cardioembolic

  • 8/6/2019 cns diseases1

    86/304

    11/07/11 MUN FP Academic Half Day 86

    Cardioembolic

    Atrial fibrillation

    Mural thrombus

    Myocardial infarction

    Dilated cardiomyopathy

    Valvular lesions

    Mitral stenosis

    Mechanical valve Bacterial endocarditis

    Paradoxical embolus

    Atrial septal defect

    Patent foramen ovale

    Atrial septal aneurysm

    Spontaneous echo contrast

  • 8/6/2019 cns diseases1

    87/304

  • 8/6/2019 cns diseases1

    88/304

    Cardiogenic

  • 8/6/2019 cns diseases1

    89/304

    11/07/11 MUN FP Academic Half Day 89

    Cardiogenic

    CardiogenicMitral valve calcification Atrial myxoma Intracardiac tumor

    Marantic endocarditis Libman-Sacks endocarditis

    Subarachnoid hemorrhage vasospasmDrugs: cocaine, amphetamine

    Moyamoya disease Eclampsia

  • 8/6/2019 cns diseases1

    90/304

    11/07/11 MUN FP Academic Half Day 90

    Medial Medullary syndrome

    Occlusion of vertebral artery or ofbranch of vertebral or lower basilarartery

    On side of lesion

    Paralysis with atrophy of half the tongue:Ipsilateral twelfth nerve

    On side opposite lesion Paralysis of arm and leg, sparing face;

    impaired tactile and proprioceptive senseover half the body: Contra lateralpyramidal tract and medial lemniscus

  • 8/6/2019 cns diseases1

    91/304

  • 8/6/2019 cns diseases1

    92/304

    11/07/11 MUN FP Academic Half Day 92

    Lateral Medullary syndrome

    Dysphagia, hoarseness, paralysis of palate,paralysis of vocal cord, diminished gag reflex:

    Issuing fibers ninth and tenth nerves Loss of taste: Nucleus and Tractus Solitarius

    Numbness of ipsilateral arm, trunk, or leg:Cuneate and Gracile nuclei Weakness of lower face: Genuflectedupper motor

    neuron fibers to ipsilateral facial nucleus On side opposite lesion Impaired pain and thermal sense over half the

    body, sometimes face: Spinothalamic tract

  • 8/6/2019 cns diseases1

    93/304

    11/07/11 MUN FP Academic Half Day 93

    Basilar artery syndrome

    The syndrome of the lone vertebralartery is equivalent: A combination ofthe various brainstem syndromesplus those arising in the posterior

    cerebral artery distribution. Bilateral long tract signs (sensory andmotor; Cerebellar and peripheral cranialnerve abnormalities): Bilateral long tract;Cerebellar and peripheral cranial nerves

    Paralysis or weakness of all extremities,plus all bulbar musculature: Corticobulbarand corticospinal tracts bilaterally

  • 8/6/2019 cns diseases1

    94/304

    11/07/11 MUN FP Academic Half Day 94

    Medial inferior pontine syndrome

    Occlusion of Para median branch ofbasilar artery

    On side of lesion Paralysis of conjugate gaze to side of

    lesion (preservation of convergence):Center for conjugate lateral gaze

    Nystagmus: Vestibular nucleus Ataxia of limbs and gait: Likely Middle

    Cerebellar Peduncle Diplopia on lateral gaze:Abducens

    nerve

  • 8/6/2019 cns diseases1

    95/304

    11/07/11 MUN FP Academic Half Day 95

    Medial inferior pontine syndrome

    On side opposite lesion

    Paralysis of face, arm, and leg:Corticobulbar and corticospinal

    tract in lower Pons Impaired tactile and proprioceptive

    sense over half of the body: Medial

    lemniscus

  • 8/6/2019 cns diseases1

    96/304

  • 8/6/2019 cns diseases1

    97/304

    11/07/11 MUN FP Academic Half Day 97

    Lateral inferior pontine syndrome

    On side opposite lesion

    Impaired pain and thermal senseover half the body (may include

    face): Spinothalamic tract

  • 8/6/2019 cns diseases1

    98/304

    11/07/11 MUN FP Academic Half Day 98

    Medial mid pontine syndrome

    Medial midpontine syndrome (paramedianbranch of midbasilar artery)

    On side of lesion Ataxia of limbs and gait (more prominent

    in bilateral involvement): Pontine nuclei On side opposite lesion Paralysis of face, arm, and leg:

    Corticobulbar and corticospinal tract

    Variable impaired touch andproprioception when lesion extendsposteriorly: Medial lemniscus

  • 8/6/2019 cns diseases1

    99/304

    11/07/11 MUN FP Academic Half Day 99

    Lateral mid pontine syndrome

    Lateral mid pontine syndrome (shortcircumferential artery)

    On side of lesion Ataxia of limbs: Middle cerebellar peduncle

    Paralysis of muscles of mastication: Motor fibersor nucleus of fifth nerve

    Impaired sensation over side of face: Sensoryfibers or nucleus of fifth nerve

    On side opposite lesion

    Impaired pain and thermal sense on limbs andtrunk: Spinothalamic tract

  • 8/6/2019 cns diseases1

    100/304

    11/07/11 MUN FP Academic Half Day 100

    Medial superior pontine syndrome

    Medial superior pontine syndrome (paramedianbranches of upper basilar artery) On side of lesion

    Cerebellar ataxia (probably): Superior and/or middlecerebellar peduncle

    Internuclear ophthalmoplegia: Medial longitudinal

    fasciculus Myoclonic syndrome, palate, pharynx, vocal cords,respiratory apparatus, face, oculomotor apparatus,etc.: Localization uncertaincentral tegmental bundle,dentate projection, inferior olivary nucleus

    On side opposite lesion Paralysis of face, arm, and leg: Corticobulbar and

    corticospinal tract

    Rarely touch, vibration, and position are affected:Medial lemniscus

  • 8/6/2019 cns diseases1

    101/304

  • 8/6/2019 cns diseases1

    102/304

    11/07/11 MUN FP Academic Half Day 102

    Medial midbrain syndrome

    Medial midbrain syndrome (paramedianbranches of upper basilar and proximalposterior cerebral arteries) On side of lesion

    Eye "down and out" secondary to unopposedaction of fourth and sixth cranial nerves, withdilated and unresponsive pupil: Third nervefibers

    On side opposite lesion Paralysis of face, arm, and leg: Corticobulbar

    and corticospinal tract descending in cruscerebri

  • 8/6/2019 cns diseases1

    103/304

    11/07/11 MUN FP Academic Half Day 103

    Lateral midbrain syndrome

    Lateral midbrain syndrome (syndrome ofsmall penetrating arteries arising fromposterior cerebral artery) On side of lesion

    Eye "down and out" secondary to unopposedaction of fourth and sixth cranial nerves, withdilated and unresponsive pupil: Third nerve fibersand/or third nerve nucleus

    On side opposite lesion

    Hemiataxia, hyperkinesias, tremor: Red nucleus,dentatorubrothalamic pathway

  • 8/6/2019 cns diseases1

    104/304

    11/07/11 MUN FP Academic Half Day 104

    Lateral superior pontine syndrome

    On side opposite lesion Impaired pain and thermal sense on

    face, limbs, and trunk: Spinothalamictract

    Impaired touch, vibration, and positionsense, more in leg than arm (there is atendency to incongruity of pain andtouch deficits): Medial lemniscus (lateralportion)

    Intravenous Recombinant Tissue

  • 8/6/2019 cns diseases1

    105/304

    11/07/11 MUN FP Academic Half Day 105

    Plasminogen Activator

    Indication Clinical diagnosis of stroke

    Onset of symptoms to time of drugadministration 3 h

    CT scan showing no hemorrhage oredema of > of the MCA territory

    Age 18 years

    Consent by patient or surrogate

    Contraindication

  • 8/6/2019 cns diseases1

    106/304

    11/07/11 MUN FP Academic Half Day 106

    Sustained BP >185/110 despite treatment Platelets

  • 8/6/2019 cns diseases1

    107/304

    11/07/11 MUN FP Academic Half Day 107

  • 8/6/2019 cns diseases1

    108/304

    11/07/11 MUN FP Academic Half Day 108

  • 8/6/2019 cns diseases1

    109/304

    11/07/11 MUN FP Academic Half Day 109

    Medial brain stem syndromes

    1. Medial midbrain syndrome paramedian branches ofupper basilar and proximal

    posterior cerebral arteries 3. Medial superior pontine syndrome Paramedian branches ofupper basilar artery 4. Medial midpontine syndrome Paramedian branch ofmidbasilar artery 5. Medial inferior pontine syndrome Occlusion of paramedian branch ofbasilar artery 9. Medial Medullary syndrome Occlusion ofvertebral artery or of branch of

    vertebral or lower basilar artery

  • 8/6/2019 cns diseases1

    110/304

    11/07/11 MUN FP Academic Half Day 110

    Lateral brain stem syndromes

    2. Lateral midbrain syndrome Syndrome ofsmall penetrating arteries arising from

    posterior cerebral artery 6. Lateral superior pontine syndrome Syndrome ofsuperior Cerebellar artery 7. Lateral midpontine syndrome Short circumferential artery 8. Lateral inferior pontine syndrome Occlusion ofanterior inferior Cerebellar artery Lateral medullary syndrome: Occlusion of any of five vessels may be responsible

    vertebral, posterior inferior Cerebellar, superior,

    middle, or inferior lateral Medullary arteries

  • 8/6/2019 cns diseases1

    111/304

    11/07/11 MUN FP Academic Half Day 111

    Medial brain stem syndromes

    Paralysis of face, arm, and leg: Corticobulbar and corticospinal tract descending in crus cerebri Paralysis of face, arm, and leg: Corticobulbar and corticospinal tract Rarely touch, vibration, and position are affected Medial lemniscus Paralysis of face, arm, and leg: Corticobulbar and corticospinal tract

    Variable impaired touch and proprioception when lesion extends posteriorly: Medial lemniscus Paralysis of face, arm, and leg: Corticobulbar and corticospinal tract in lower Pons Impaired tactile and proprioceptive sense over half of the body: Medial lemniscus Paralysis of arm and leg, sparing face; impaired tactile and proprioceptive

    sense over half the body: Contra lateral pyramidal tract and medial lemniscus

  • 8/6/2019 cns diseases1

    112/304

    11/07/11 MUN FP Academic Half Day 112

    Lateral brain stem syndromes

    Hemiataxia, hyperkinesias, tremor: Red nucleus, dentatorubrothalamic pathway Impaired pain and thermal sense on face, limbs,

    and trunk: Spinothalamic tract Impaired touch, vibration, and position sense, more

    in leg than arm (there is a tendency to incongruityof pain and touch deficits): Medial lemniscus(lateral portion)

    Impaired pain and thermal sense on limbs andtrunk: Spinothalamic tract

    Impaired pain and thermal sense over half the body(may include face): Spinothalamic tract

    Impaired pain and thermal sense over half the bodysometimes face: Spinothalamic tract

    Lateral Medullary syndrome

  • 8/6/2019 cns diseases1

    113/304

    11/07/11 MUN FP Academic Half Day 113

    (occlusion of any of five vessels may be responsiblevertebral, posteriorinferior Cerebellar, superior, middle, or inferior lateral Medullary arteries)

    On side of lesion 1. Pain, numbness, impaired sensation over half the face: Descending tract and nucleus fifth nerve 2. Ataxia of limbs, falling to side of lesion: Uncertain Restiform body, Cerebellar hemisphere, Cerebellar fibers, spino Cerebellar

    tract (?) 3. Nystagmus, diplopia, oscillopsia, vertigo, nausea, vomiting: Vestibular nucleus 4. Horner's syndrome (miosis, ptosis, decreased sweating): Descending sympathetic tract 5. Dysphagia, hoarseness, paralysis of palate, paralysis of vocal cord, diminished gag

    reflex: Issuing fibers ninth and tenth nerves 6. Loss of taste: Nucleus and tractus solitarius 7. Numbness of ipsilateral arm, trunk, or leg: Cuneate and gracile nuclei 8. Weakness of lower face: Genuflected upper motor neuron fibers to ipsilateral facial nucleus

    Lateral midbrain syndrome

  • 8/6/2019 cns diseases1

    114/304

    11/07/11 MUN FP Academic Half Day 114

    syndrome of small penetrating arteriesarising from posterior cerebral artery

    On side of lesion Eye "down and out" secondary to unopposed

    action of fourth and sixth cranial nerves, withdilated and unresponsive pupil: Third nerve fibers and/or third nerve

    nucleus On side opposite lesion

    Hemiataxia, hyperkinesias, tremor: Red nucleus, dentatorubrothalamic pathway

    Lateral superior pontine syndrome (syndrome of

  • 8/6/2019 cns diseases1

    115/304

    11/07/11 MUN FP Academic Half Day 115

    ate a supe o po t e sy d o e (sy d o e o

    superior Cerebellar artery)

    On side of lesion Ataxia of limbs and gait, falling to side of lesion: Middle and superior Cerebellar peduncles, superior surface of cerebellum,

    dentate nucleus Dizziness, nausea, vomiting; horizontal Nystagmus: Vestibular nucleus Paresis of conjugate gaze (ipsilateral):

    Pontine contra lateral gaze 4. Skew deviation: Uncertain 5. Miosis, ptosis, decreased sweating over face (Horner's syndrome): Descending sympathetic fibers 6. Tremor: Localization unclear Dentate nucleus, superior Cerebellar peduncle On side opposite lesion Impaired pain and thermal sense on face, limbs, and trunk: Spinothalamic tract Impaired touch, vibration, and position sense, more in leg than arm (there is a

    tendency to incongruity of pain and touch deficits): Medial lemniscus (lateral portion)

    Lateral midpontine syndrome

  • 8/6/2019 cns diseases1

    116/304

    11/07/11 MUN FP Academic Half Day 116

    Short circumferential artery

    On side of lesion 1. Ataxia of limbs: Middle Cerebellar

    peduncle 2. Paralysis of muscles of mastication:

    Motor fibers or nucleus of fifth nerve 3. Impaired sensation over side of face: Sensory fibers or nucleus of fifth

    nerve

    On side opposite lesion Impaired pain and thermal sense on limbsand trunk: Spinothalamic tract

    Lateral inferior pontine syndrome

  • 8/6/2019 cns diseases1

    117/304

    11/07/11 MUN FP Academic Half Day 117

    Lateral inferior pontine syndrome

    occlusion of anterior inferior Cerebellar artery

    On side of lesion 1.Horizontal and vertical Nystagmus, vertigo, nausea,

    vomiting, oscillopsia: Vestibular nerve or nucleus 2.Facial paralysis: Seventh nerve Paralysis of conjugate gaze to side of lesion: Center

    for conjugate lateral gaze 3.Deafness, tinnitus:Auditory nerve or cochlearnucleus

    4.Ataxia: Middle Cerebellar peduncle andCerebellar hemisphere

    5.Impaired sensation over face: Descending tractand nucleus fifth nerve

    On side opposite lesion Impaired pain and thermal sense over half the body

    (may include face): Spinothalamic tract

    Medial Medullary syndrome

    Occlusion of vertebral artery or of branch of vertebral or lower

    basilar artery

  • 8/6/2019 cns diseases1

    118/304

    11/07/11 MUN FP Academic Half Day 118

    basilar artery

    On side of lesion

    Paralysis with atrophy of half the tongue:Ipsilateral twelfth nerve

    On side opposite lesion Paralysis of arm and leg, sparing face;

    impaired tactile and proprioceptive senseover half the body:

    Contra lateral pyramidal tract andmedial lemniscus

    Medial midbrain syndrome

    paramedian branches of upper basilar and proximal posterior

    cerebral arteries

  • 8/6/2019 cns diseases1

    119/304

    11/07/11 MUN FP Academic Half Day 119

    cerebral arteries

    On side of lesion Eye "down and out" secondary to

    unopposed action of fourth and sixthcranial nerves, with dilated and

    unresponsive pupil: Third nerve fibers On side opposite lesion Paralysis of face, arm, and leg: Corticobulbar and corticospinal tract

    descending in crus cerebri

    Medial superior pontine syndrome

    (paramedian branches of upper basilar artery)

  • 8/6/2019 cns diseases1

    120/304

    11/07/11 MUN FP Academic Half Day 120

    (paramedian branches of upper basilar artery)

    On side of lesion 1. Cerebellar ataxia (probably): Superior and/or middle Cerebellar peduncle 2. Internuclear ophthalmoplegia: Medial longitudinal fasciculus 3. Myoclonic syndrome, palate, pharynx, vocal cords,

    respiratory apparatus, face, oculomotor apparatus, etc.:Localization uncertain

    central tegmental bundle, dentate projection, inferiorolivary nucleus

    On side opposite lesion Paralysis of face, arm, and leg: Corticobulbar and

    corticospinal tract Rarely touch, vibration, and position are affected: Medial lemniscus

    Medial midpontine syndrome

    Paramedian branch of midbasilar artery

  • 8/6/2019 cns diseases1

    121/304

    11/07/11 MUN FP Academic Half Day 121

    Paramedian branch of midbasilar artery

    On side of lesion Ataxia of limbs and gait (more prominent

    in bilateral involvement): Pontine nuclei On side opposite lesion Paralysis of face, arm, and leg:

    Corticobulbar and corticospinal tract Variable impaired touch and

    proprioception when lesion extendsposteriorly: Medial lemniscus

    Medial inferior pontine syndrome

  • 8/6/2019 cns diseases1

    122/304

    11/07/11 MUN FP Academic Half Day 122

    Medial inferior pontine syndrome

    occlusion of paramedian branch of basilar artery

    On side of lesion 1.Paralysis of conjugate gaze to side of lesion

    (preservation of convergence): Center for conjugate lateral gaze 2.Nystagmus: Vestibular nucleus 3.Ataxia of limbs and gait: Likely middle

    Cerebellar peduncle 4.Diplopia on lateral gaze:Abducens nerve On side opposite lesion Paralysis of face, arm, and leg: Corticobulbar

    and corticospinal tract in lower Pons Impaired tactile and proprioceptive sense over

    half of the body: Medial lemniscus

    On side opposite lesion

  • 8/6/2019 cns diseases1

    123/304

    11/07/11 MUN FP Academic Half Day 123

    1. Medial midbrain syndrome paramedian branches of upper basilar and

    proximal posterior cerebral arteries Paralysis of face, arm, and leg:

    Corticobulbar and corticospinal tractdescending in crus cerebri 2. Lateral midbrain syndrome Syndrome of small penetrating arteries

    arising from posterior cerebral artery

    Hemiataxia, hyperkinesias, tremor: Red nucleus, dentatorubrothalamic pathway

    M di l ti d

  • 8/6/2019 cns diseases1

    124/304

    11/07/11 MUN FP Academic Half Day 124

    Medial pontine syndromes

    3. Medial superior pontine syndrome (Paramedian branches of upper basilar artery) Paralysis of face, arm, and leg: Corticobulbar and corticospinal tract Rarely touch, vibration, and position are affected Medial lemniscus 4. Medial midpontine syndrome Paramedian branch of midbasilar artery

    Paralysis of face, arm, and leg: Corticobulbar and corticospinal tract Variable impaired touch and proprioception when lesion extends posteriorly: Medial lemniscus 5. Medial inferior pontine syndrome (Occlusion of paramedian branch of basilar artery) Paralysis of face, arm, and leg: Corticobulbar and corticospinal tract in lower Pons Impaired tactile and proprioceptive sense over half of the body:

    Medial lemniscus

    L t l ti d

  • 8/6/2019 cns diseases1

    125/304

    11/07/11 MUN FP Academic Half Day 125

    Lateral pontine syndromes

    6. Lateral superior pontine syndrome (Syndrome of superior Cerebellar artery) Impaired pain and thermal sense on face, limbs, and trunk: Spinothalamic tract Impaired touch, vibration, and position sense, more in leg than

    arm (there is a tendency to incongruity of pain and touchdeficits):

    Medial lemniscus (lateral portion) 7. Lateral midpontine syndrome Short circumferential artery Impaired pain and thermal sense on limbs and trunk: Spinothalamic tract 8. Lateral inferior pontine syndrome (occlusion of anterior

    inferior Cerebellar artery)

    Impaired pain and thermal sense over half the body (mayinclude face): Spinothalamic tract

    Contra lateral

  • 8/6/2019 cns diseases1

    126/304

    11/07/11 MUN FP Academic Half Day 126

    Contra lateral

    9. Medial Medullary syndrome Occlusion of vertebral artery or of branch of vertebral

    or lower basilar artery Paralysis of arm and leg, sparing face; impaired tactile

    and proprioceptive sense over half the body: Contra lateral pyramidal tract and medial lemniscus

    10. Lateral medullary syndrome: (Occlusion of any of five vessels may be responsible

    vertebral, posterior inferior Cerebellar, superior,middle, or inferior lateral Medullary arteries)

    Impaired pain and thermal sense over half the bodysometimes face:

    Spinothalamic tract

    BRAIN STEM SYNDROMES

  • 8/6/2019 cns diseases1

    127/304

    11/07/11 MUN FP Academic Half Day 127

    BRAIN-STEM SYNDROMES

    WEBER (ANTERIOR CEREBRALPEDUNCLE MIDBRAIN)IL3+CL7UMN+CLHP

    CLAUDE; CEREBRAL PEDUNCLEINVOLVING RED NUCLEUS IL3 + CLCEREBELLAR SIGNS

    PARINAUD;

  • 8/6/2019 cns diseases1

    128/304

    11/07/11 MUN FP Academic Half Day 128

    PARINAUD;

    DORSAL MB/ TECTUM

    VERTICAL GAZE PALSY+

    CONVERGENCE DISORDERS +

    CONVERGENCE RETRACTION+

    NYSTAGMUS+

    PUPILLARY & LID DISORDERS

  • 8/6/2019 cns diseases1

    129/304

    WALLENBERG;LATERAL MEDULLARY

    SYNDROME

  • 8/6/2019 cns diseases1

    130/304

    11/07/11 MUN FP Academic Half Day 130

    SYNDROME;

    IL5,7,9,10,11+IL HONER+ILCEREBELLAR+

    CL SPINOTHALAMIC

    VESTIBULAR DISTURBANCE.

    Vernet 9 10 11

  • 8/6/2019 cns diseases1

    131/304

    11/07/11 MUN FP Academic Half Day 131

    Vernet 9,10,11

    Jugular foramen (inside the skull)

    Metastases, neurinoma,meningioma, Epidermoid & carotid

    body tumor.

    Collet Sicard 9 10 11 12

  • 8/6/2019 cns diseases1

    132/304

    11/07/11 MUN FP Academic Half Day 132

    Collet Sicard 9,10,11,12

    Jugular foramen (out side the skullnear foramen lacerum)

    Metastases, neurinoma,

    meningioma, Epidermoid & carotidbody tumor.

    Villaret 9 10 11 12 & Horner's

  • 8/6/2019 cns diseases1

    133/304

    11/07/11 MUN FP Academic Half Day 133

    Villaret 9,10,11,12 & Horner s

    Posterior retropharyngeal spacenear carotid artery

    Carotid dissection, Metastases,

    neurinoma, meningioma,Epidermoid & carotid body tumor.

  • 8/6/2019 cns diseases1

    134/304

  • 8/6/2019 cns diseases1

    135/304

    11/07/11 MUN FP Academic Half Day 135

  • 8/6/2019 cns diseases1

    136/304

    11/07/11 MUN FP Academic Half Day 136

  • 8/6/2019 cns diseases1

    137/304

    11/07/11 MUN FP Academic Half Day 137

  • 8/6/2019 cns diseases1

    138/304

    11/07/11 MUN FP Academic Half Day 138

  • 8/6/2019 cns diseases1

    139/304

    11/07/11 MUN FP Academic Half Day 139

  • 8/6/2019 cns diseases1

    140/304

    11/07/11 MUN FP Academic Half Day 140

  • 8/6/2019 cns diseases1

    141/304

  • 8/6/2019 cns diseases1

    142/304

    11/07/11 MUN FP Academic Half Day 142

  • 8/6/2019 cns diseases1

    143/304

  • 8/6/2019 cns diseases1

    144/304

  • 8/6/2019 cns diseases1

    145/304

    11/07/11 MUN FP Academic Half Day 145

  • 8/6/2019 cns diseases1

    146/304

    11/07/11 MUN FP Academic Half Day 146

  • 8/6/2019 cns diseases1

    147/304

    Haemophilus Influenzae type b (Hib)

  • 8/6/2019 cns diseases1

    148/304

    11/07/11 MUN FP Academic Half Day 148

    Meningococcus Pneumococcus

    MeningococcusMening

    ococcus

  • 8/6/2019 cns diseases1

    149/304

    11/07/11 MUN FP Academic Half Day 149

    MeningococcusMeningococcus

    common organisms that cause meningitis inchildren.

    caused by bacteria called Neisseria meningitidis.

    There are several strains of Neisseriameningitidis.

    Strain BStrain B causes about 75 percent of themeningococcal cases and has the highest fatalityfatalityrate.rate.

  • 8/6/2019 cns diseases1

    150/304

    11/07/11 MUN FP Academic Half Day 150

    Haemophilus Influenzae type B (Hib)Haemophilus Influenzae type B (Hib)

    is caused by haemophilus bacteria. It

    was once the most common form ofbacterial meningitis,

    one of the deadliest childhooddeadliest childhooddiseases.

    PneumococcusPneumococcus

  • 8/6/2019 cns diseases1

    151/304

    11/07/11 MUN FP Academic Half Day 151

    PneumococcusPneumococcus

    is caused bypneumococcus bacteria,which also cause several diseases of therespiratory system, including

    pneumonia. It has a fatality rate of about 20 percent.

    It also results in a higher incidence of

    brain damagebrain damage than other forms of thedisease.

    SymptomsSy

    mptoms

  • 8/6/2019 cns diseases1

    152/304

    11/07/11 MUN FP Academic Half Day 152

    SymptomsSymptoms

    Symptoms of meningitis can come on very quickly or take a couple of days to

    appear. Most cases ofmeningitis occur in the first 5 years of lifemeningitis occur in the first 5 years of life, with the peak

    incidence between 3 and 5 monthsbetween 3 and 5 months of age.

    Older people:

  • 8/6/2019 cns diseases1

    153/304

    11/07/11 MUN FP Academic Half Day 153

    Older people:

    1. Lethargy2. Recurring headaches

    3. Difficulty in concentration

    4. Short-term memory loss

    5. Clumsiness

    6. Balance problems

    7. Depression

    Serious complicationsSerious comp

    lications

  • 8/6/2019 cns diseases1

    154/304

    11/07/11 MUN FP Academic Half Day 154

    Serious complicationsSe ous co p ca o s

    Other seriouscomplications caninclude:

    1. Brain damage

    1. Epilepsy

    2. Changes in eye sight

    SUMMARYSUMMARY

  • 8/6/2019 cns diseases1

    155/304

    11/07/11 MUN FP Academic Half Day 155

    SUMMARY

    Meningitis is an inflammation of theprotective membrane lining the brainand spinal cord caused most often by aviral or bacterial infection that crossesthe body's blood-brain barrier.

    Meningitis is diagnosed by a lumbarpuncture , in which a small amount offluid is collected from the spinalcolumn.

    There are two main types of

    meningitis: bacterial and viral.Bacterial meningitis is less common,but more serious.

    SUMMARYSUMMARY

  • 8/6/2019 cns diseases1

    156/304

    11/07/11 MUN FP Academic Half Day 156

    SU

    Bacterial meningitis is treated with antibiotics and themajority of patients make a full recovery.

    Viral meningitis usually requires no treatment beyondpainkillers.

    Most patients make a full recovery from meningitis. Asmall number of infected people end up with hearing or

    vision loss or brain damage. Vaccinations against some forms of meningitis are

    available. They are recommended for children under age5, people in close contact with someone who hasdeveloped meningitis, college students, and peopletraveling to certain overseas destinations.

  • 8/6/2019 cns diseases1

    157/304

  • 8/6/2019 cns diseases1

    158/304

  • 8/6/2019 cns diseases1

    159/304

    11/07/11 MUN FP Academic Half Day 159Clin Microbiol Infect 2003;9;803-809

  • 8/6/2019 cns diseases1

    160/304

    11/07/11 MUN FP Academic Half Day 160 Clin Microbiol Infect 2003;9;803-809

    PREDISPOSING FACTORS

  • 8/6/2019 cns diseases1

    161/304

    11/07/11 MUN FP Academic Half Day 161

    IVDA (2.5%)

    Congenital heart disease (6.1%)

    HIV infection (1.2%)

    Immunosuppression (3.7%)

    Diabetes mellitus (3.1%)

    Stages

  • 8/6/2019 cns diseases1

    162/304

    11/07/11 MUN FP Academic Half Day 162

    g

    1. Early cerebritis stage (D1-3):focal area ofinflammation and edema

    2. Late cerebritis stage (D4-9):development of anecrotic central focus

    3. Early capsule stage (D10-14):ring-enhancing

    capsule of well-vascularized tissue with earlyappearance of peripheral fibrosis

    4. Late capsule stage (>D14):host defenses lead toa well-formed capsule

    ~Clin Infect Dis. 1997 Oct;25(4):763-79

  • 8/6/2019 cns diseases1

    163/304

    IMAGING STUDIES

  • 8/6/2019 cns diseases1

    164/304

    11/07/11 MUN FP Academic Half Day 164

    2. MRI

    T1: hypointense with ring-enhancement

    T2: hyperintense central area of pussurrounded by a well-defined hypointensecapsule & edema-> surgery

    3. Radionuclide scan

    D/D brain abscess from tumor

  • 8/6/2019 cns diseases1

    165/304

    11/07/11 MUN FP Academic Half Day 165

    CerebellumCerebellumFunctionFunction

    CerebellumCerebellumFunctionFunction

  • 8/6/2019 cns diseases1

    166/304

    11/07/11 MUN FP Academic Half Day

    Maintenance of EquilibriumMaintenance of Equilibrium - balance, posture, eye movement- balance, posture, eye movement

    Coordination of half-automatic movement ofCoordination of half-automatic movement ofwalking and posture maintenacewalking and posture maintenace- posture, gait- posture, gait

    Adjustment of Muscle ToneAdjustment of Muscle Tone

    Motor Leaning Motor SkillsMotor Leaning Motor SkillsCognitive FunctionCognitive Function

    Motor SkillMotor Skill

  • 8/6/2019 cns diseases1

    167/304

    11/07/11 MUN FP Academic Half Day 167

    Motor SkillMotor Skill

    Pablo CasalsPablo CasalsPablo CasalsPablo Casals

    CerebellumCerebellum ClinicalClinicalSyndromesSyndromes

    CerebellumCerebellum ClinicalClinicalSyndromesSyndromes

  • 8/6/2019 cns diseases1

    168/304

    11/07/11 MUN FP Academic Half Day

    AtaxiaAtaxia: incoordination of movement: incoordination of movement - decomposition of movement- decomposition of movement

    - dysmetria, past-pointing- dysmetria, past-pointing

    - dysdiadochokinesia- dysdiadochokinesia

    - rebound phenomenon of Holmes- rebound phenomenon of Holmes- gait ataxia, truncal ataxia, titubation- gait ataxia, truncal ataxia, titubation

    IntentionIntention TremorTremor

    Hypotonia,Hypotonia, NystagmusNystagmus

    Archicerebellar LesionArchicerebellar Lesion: medulloblastoma: medulloblastomaPaleocerebellar LesionPaleocerebellar Lesion: gait disturbance: gait disturbance

    Neocerebellar LesionNeocerebellar Lesion: hypotonia, ataxia, tremor: hypotonia, ataxia, tremor

    CerebellarCerebellara b c

  • 8/6/2019 cns diseases1

    169/304

    11/07/11 MUN FP Academic Half Day 169

    CerebellarCerebellar

    AtaxiaAtaxia

    Ataxic gait andAtaxic gait and

    position:position:

    Left cerebellar tumorLeft cerebellar tumor

    a. Sways to the right ina. Sways to the right in

    standing positionstanding position

    b. Steady on theb. Steady on the

    right legright leg

    c. Unsteady on thec. Unsteady on the

    left legleft leg

    d. ataxic gaitd. ataxic gait

    d

    CerebellarCerebellar

  • 8/6/2019 cns diseases1

    170/304

    11/07/11 MUN FP Academic Half Day 170

    Cerebellar tumors onCerebellar tumors on vermisvermis

    - Truncal Ataxia- Truncal Ataxia

    - Frequent Falling- Frequent Falling

    The child in this picture:The child in this picture:

    - would not try to stand- would not try to stand

    unsupportedunsupported- would not let go of the bed rail- would not let go of the bed rail

    if she was stood on the floor.if she was stood on the floor.

    MedulloblastomaMedulloblastoma

  • 8/6/2019 cns diseases1

    171/304

    11/07/11 MUN FP Academic Half Day 171

    BalanceBalance

    What is Multiple Sclerosis?What is Multiple Sclerosis?

  • 8/6/2019 cns diseases1

    172/304

    11/07/11 MUN FP Academic Half Day 172

    It is an Auto Immune Diseasewhich is when the body starts todestroy itself.

    It is a life-long disease with no

    cure. In MS, the body attacks anddestroys the fatty tissue calledmyelin that insulates anaxon/nerve, and is calleddemyelination.

    What is Multiple Sclerosis?

  • 8/6/2019 cns diseases1

    173/304

    11/07/11 MUN FP Academic Half Day 173

    Multiple Sclerosis (MS) is an chronicinflammatory demyelinating diseaseof the brain and spinal cord.

    The Human Nervous System

  • 8/6/2019 cns diseases1

    174/304

    11/07/11 MUN FP Academic Half Day 174

    Areas affected byMS Brain

    Spinal cord

    Optic nerves

    (http://web.lemoyne.edu/~hevern/psy340/lectures/psy340.04.2.ns.structure.html)

    Initial Presentation of MS

  • 8/6/2019 cns diseases1

    175/304

    11/07/11 MUN FP Academic Half Day 175

    Incidence(%)

    Optic nerve inflammation 1429

    Poor balance (ataxia) 218

    Dizziness (vertigo) 29

    Weakness 1040

    Double visions (diplopia) 818

    Bladder, bowel dysfunction 014

    Pain 2140

    Sensory loss 1339

    Other Common Symptoms of MS

  • 8/6/2019 cns diseases1

    176/304

    11/07/11 MUN FP Academic Half Day 176

    FatigueSpasticity

    Sexual dysfunction

    Cognitive impairmentGenerally occurs later in thedisease

    Multiple Sclerosis Clinical SubtypesMultiple Sclerosis Clinical Subtypes

    Relapsing-remitting Secondary-progressive

  • 8/6/2019 cns diseases1

    177/304

    11/07/11 MUN FP Academic Half Day 177

    Lublin FD et al. Neurology. 1996;46:907-911.

    p g g

    Primary-progressive

    Dis

    abilit

    y

    Time

    Time

    Dis

    abilit

    y

    y p g

    Progressive-relapsing

    Time

    Time

    Dis

    abilit

    y

    Dis

    abilit

    y

    How Is MS Diagnosed?

  • 8/6/2019 cns diseases1

    178/304

    11/07/11 MUN FP Academic Half Day 178

    At least two episodes of symptomsOccur at different points in time

    Result from involvement of different areas

    of the central nervous system Absence of other treatable causes for

    the symptoms

    Results of neurological testing

    Other Potential Causes of

    MS-like Symptoms

  • 8/6/2019 cns diseases1

    179/304

    11/07/11 MUN FP Academic Half Day 179

    Lyme disease

    Lupus

    Migraine

    Non-recurrent inflammatory process Encephalitis

    Stroke

    Tumor of the brain or spinal cord

    Brain Atrophy (Shrinkage)

    in Untreated MS

  • 8/6/2019 cns diseases1

    180/304

    11/07/11 MUN FP Academic Half Day 180

    Images acquired over the course of 7 years

    from a single person with untreated MS

    Brain Atrophy (Shrinkage)

    in Untreated MS

  • 8/6/2019 cns diseases1

    181/304

    11/07/11 MUN FP Academic Half Day 181

    Treatment of New MS Exacerbations

  • 8/6/2019 cns diseases1

    182/304

    11/07/11 MUN FP Academic Half Day 182

    Drug therapyCorticosteroids

    Intravenous immunoglobulin

    Plasma exchange Physical therapy

  • 8/6/2019 cns diseases1

    183/304

    11/07/11 MUN FP Academic Half Day 183

    Glatiramer

    acetate

    Prevention of Future Attacks and

    Disease Progression

  • 8/6/2019 cns diseases1

    184/304

    11/07/11 MUN FP Academic Half Day 184

    Immune modulating drugsBeta-Interferon

    Glatiramer acetate

    Humanized monoclonal antibodies Immunosuppressant drugs

    Anti-cancer agents

    Combination therapies

    Symptom Management Examples

  • 8/6/2019 cns diseases1

    185/304

    11/07/11 MUN FP Academic Half Day 185

    Pain control

    Management of impaired bladderand bowel function

    Anti-spasmodic drugs Treatment of fatigue

    Splinting for contractures

    Counseling

    MS Therapies: What Lies Ahead?

  • 8/6/2019 cns diseases1

    186/304

    11/07/11 MUN FP Academic Half Day 186

    Neural protection Regenerative therapies

    Cell replacement (stem cells)

    Dietary approaches (vitamin D)

    Multiple SclerosisMultiple Sclerosis

  • 8/6/2019 cns diseases1

    187/304

    11/07/11 MUN FP Academic Half Day 187

    If damage is severe it can also destroy the nerve/axonitself.

    MS affects the central nervous system and inflamesthe white matter in the brain which creates plaques.White matter is below the top layer of our brain andspinal cord. Plaques block a signal from being passedfrom the body to the spinal cord and brain.

    Currently in the US, 250,000-300,000 people havebeen diagnosed with MS and there are 200 new casesdiagnosed every week.

    Diagnostic categories of MS

  • 8/6/2019 cns diseases1

    188/304

    11/07/11 MUN FP Academic Half Day 188

    The phrase multiple abnormalitiesin space and time sums up what aphysician needs to find a diagnosis

    of MS (OConnor 32). There are three categories of MS;

    Definite, Probable, and Possible MS.

    Possible MS:

  • 8/6/2019 cns diseases1

    189/304

    11/07/11 MUN FP Academic Half Day 189

    There is no documented signsof MS and more than onelesion.

    There is also a history of onerelapse-remitting symptoms.

  • 8/6/2019 cns diseases1

    190/304

    Definite MS:

  • 8/6/2019 cns diseases1

    191/304

    11/07/11 MUN FP Academic Half Day 191

    Consistent course (relapse-remittingcourse with at least 2 bouts separated by atleast 1 month or

    slow or stepwise progressive course for at

    least 6 months) of documented neurologicalsigns of lesions in more than one site ofbrain or spinal cord white matter ( Hope7).

    The age of onset is between 10 and 50

    years of age.

    Symptoms of MSSymptoms of MS

  • 8/6/2019 cns diseases1

    192/304

    11/07/11 MUN FP Academic Half Day 192

    Fatigue Depression

    Memory change

    Pain

    Spasticity Vertigo

    Tremor

    Double Vision/Vision

    Loss

    Weakness Dizziness/Unsteadines

    s

    Numbness/Tingling

    Ataxia Euphoria

    Speech disturbance

    Bladder/Bowel/Sexualdysfunction

    Medications used for MSMedications used for MS

  • 8/6/2019 cns diseases1

    193/304

    11/07/11 MUN FP Academic Half Day 193

    Spasticity- Baclofen, Tizanidine, Diazepam, Dantrolene Optic Neuritis-Methlyprednisolone, Oral steroids Fatigue-Antidepressant, Amantadine

    Pain-Codeine, Aspirin

    Sexual Dysfunction-Viagra, Pravatine Tremor-Isoniazid, Primidone, Propranolol Disease-Modifying Drugs- Interferon beta 1a and

    1b, and Glatiramer acetate

    Interferon Beta 1b(Betaseron):

  • 8/6/2019 cns diseases1

    194/304

    11/07/11 MUN FP Academic Half Day 194

    Is slightly different from our own interferon. This medication does the same thing as beta 1a,

    but is injected just under the skin every twodays.

    Side effects include irritation, bruising, and

    redness at the site of injection and the flu likesymptoms. This is also given to people whohave definite progressive MS.

    Disease-Modifying DrugsDisease-Modifying Drugs (cont)(cont)

  • 8/6/2019 cns diseases1

    195/304

    11/07/11 MUN FP Academic Half Day 195

    Glatiramer Acetate ( Copaxone): is asmall fragment of a protein that resembles a protein in

    myelin ( OConnor 106). It decrease the reoccurrence of relapse.

    It is injected just under the skin every day.

    There is no flu like symptoms but occasional rednessmay occur at the injection site. A few amount of people do experience brief shortness

    of breathe.

    In summary all three of these drugs decrease relapses

    by 33%, have manageable side effect, are injected,stabilize the disease, and tend to be costly.

    Parkinson Disease

  • 8/6/2019 cns diseases1

    196/304

    11/07/11 MUN FP Academic Half Day 196

    Neurological disease affecting over four millionpatients worldwide, over 1.5 million people inthe U.S.. While it can affect individuals at anyage, it is most common in the elderly.

    The average age of onset is 55 years, althoughapproximately 10 percent of cases affect thoseunder age 40.

  • 8/6/2019 cns diseases1

    197/304

    Clinical Characteristics

  • 8/6/2019 cns diseases1

    198/304

    11/07/11 MUN FP Academic Half Day 198

    James Parkinson, 1917 ...involuntary tremulous motion, with lessened muscular power, in parts

    not in action and even when supported; with a propensity to bend the

    trunk forwards, and to pass from a walking to a funning pace, the senses

    and the intellects uninjured.

    rhythmic tremor at rest rigidity with cog-wheel characteristic

    akinesia

  • 8/6/2019 cns diseases1

    199/304

  • 8/6/2019 cns diseases1

    200/304

    ETIOLOGY

    Genetic Factors

  • 8/6/2019 cns diseases1

    201/304

    11/07/11 MUN FP Academic Half Day 201

    1999 - examined 17,000 twins

    > 50 years old: no genetic effect

    < 50 years old: 10 % genetic defect

    Diet vitamins, antioxidants incidenceSmoking incidenceEnvironment incidence in rural areas

    dopamine neuron toxins

    Normal

    Pathophysiology of Parkinsons Disease

  • 8/6/2019 cns diseases1

    202/304

    11/07/11 MUN FP Academic Half Day 202

    STRIATUM

    PALLIDUM

    SUBSTANTA

    NIGRA

    THALAMUS

    MOTOR

    CORTEX

    Pathology

    STRIATUM

    PALLIDUMSUBSTANTA

    NIGRATHALAMUS

    MOTORCORTEX

    STAGES OF PARKINSON'S DISEASE

    DOPAMINE

    (% control)

  • 8/6/2019 cns diseases1

    203/304

    11/07/11 MUN FP Academic Half Day 203

    (% control)

    ADAPTIVECAPACITY

    0

    20

    40

    60

    80

    100

    DECOMPENSATION

    COMPENSATION

    -no symptoms

    MILD SYMPTOMS

    MARKED SYMPTOMS

    Levodopa therapy

  • 8/6/2019 cns diseases1

    204/304

    11/07/11 MUN FP Academic Half Day 204

    Main treatment is with L-DOPAPrecursor for dopamine

    Sinemet is L-DOPA + carbidopacarbidopa is a peripheral decarboxylase inhibitor

    - prevents L-DOPA catabolism Main problems:

    - on/off fluctuations- dyskinesias

    - eventually doesnt work- peripheral side effects (NE and E)

    Anticholinergics help as well On-off fluctuations too great with DA agonists

    Drugs used to treat Parkinsons Disease

  • 8/6/2019 cns diseases1

    205/304

    11/07/11 MUN FP Academic Half Day 205

  • 8/6/2019 cns diseases1

    206/304

    11/07/11 MUN FP Academic Half Day 206

    Appears Later in Life

    Continuous Progressive

    Neurological Disease, therebycausing increasing disability ofmovement

    no cure

    Etiology

  • 8/6/2019 cns diseases1

    207/304

    11/07/11 MUN FP Academic Half Day 207

    Cerebral atherosclerosis

    Viral encephalitis

    Side effects of severalantipsychotic drugs (i.e.,phenothiazides, butyrophenones,

    reserpine)

    Environmental factors and neurotoxins

  • 8/6/2019 cns diseases1

    208/304

    11/07/11 MUN FP Academic Half Day 208

    Pesticides, herbicides, industrialchemicals - contain substancesthat inhibit complex I in the

    mitochondria

  • 8/6/2019 cns diseases1

    209/304

    11/07/11 MUN FP Academic Half Day 209

    In Terms of Etiology and Clinical Picture, Major

    Symptoms Involve:

  • 8/6/2019 cns diseases1

    210/304

    11/07/11 MUN FP Academic Half Day 210

    Bradykinesia- Slowness in Initiation andExecution of Voluntary Movements

    Rigidity - Increase Muscle Tone andIncrease Resistance to Movement (Armsand Legs Stiff)

    Tremor - Usually Tremor at Rest, WhenPerson Sits, Arm Shakes, Tremor StopsWhen Person Attempts to Grab Something

    Postural Instability - abnormal fixation ofposture (stoop when standing), equilibrium,and righting reflex

    Gait Disturbance - Shuffling Feet

    Usually Other Accompanied Autonomic

    Deficits Seen Later in Disease Process:

  • 8/6/2019 cns diseases1

    211/304

    11/07/11 MUN FP Academic Half Day 211

    Orthostatic Hypotension Dementia

    Dystonia

    Ophthalmoplegia Affective Disorders

  • 8/6/2019 cns diseases1

    212/304

  • 8/6/2019 cns diseases1

    213/304

  • 8/6/2019 cns diseases1

    214/304

    11/07/11 MUN FP Academic Half Day 214

    The Dopaminergic Neurons in the Basal Ganglia Aremainly affected

    Acetylcholine within striatum is a tonically activatedneuron

    It impinges on GABA Neuron by an Excitatory Action

    GABA Neuron Has an Inhibitory Action on theSubstantia Nigra from Substantia Nigra, Has aDopaminergic Feed Back Loop Back to Striatum

    Which Gets Loss Giving Signs and Symptoms ofParkinson Disease

    Basal Ganglia

  • 8/6/2019 cns diseases1

    215/304

    11/07/11 MUN FP Academic Half Day 215

    The Basal Ganglia Consists of Five LargeSubcortical Nuclei That Participate inControl of Movement:

    Caudate Nucleus

    Putamen

    Globus Pallidus

    Subthalamic Nucleus

    Substantia Nigra

    The balance of the five large Subcortical Nuclei are

    responsible for smooth motor movements

  • 8/6/2019 cns diseases1

    216/304

    11/07/11 MUN FP Academic Half Day 216

    The primary input is from the Cerebral Cortex,and the output Is directed through the thalamusback to the Prefrontal, Premotor, and MotorCortex

    The motor function of the basal ganglia aretherefore mediated by the Frontal Cortex

    Neurotransmitters in Basal Ganglia IncludeSerotonin, Acetylcholine, GABA, Enkephalin,Substance P, Glutamate, and Dopamine

    Dopamine from Substantia Nigra decreasesrelease of acetylcholine from striatum.

  • 8/6/2019 cns diseases1

    217/304

    Agents that Increase Dopamine

    functions Increasing the synthesis of dopamine - l-

  • 8/6/2019 cns diseases1

    218/304

    11/07/11 MUN FP Academic Half Day 218

    Increasing the synthesis of dopamine - l-Dopa

    Inhibiting the catabolism of dopamine -selegiline

    Stimulating the release of dopamine -amphetamine

    Stimulating the dopamine receptor sitesdirectly - bromocriptine & pramipexole

    Blocking the uptake and enhancing therelease of dopamine - amantadine

  • 8/6/2019 cns diseases1

    219/304

    L Dopa Therapy for ParkinsonDisease

  • 8/6/2019 cns diseases1

    220/304

    11/07/11 MUN FP Academic Half Day 220

    Dopamine DecarboxylaseConverts L Dopa to DopamineThat Gets Stored into Secretory

    Vesicles and Gets Releasedfrom Basal Ganglia

    Effects of L Dopa on the Symptoms of

    Parkinson Disease

  • 8/6/2019 cns diseases1

    221/304

    11/07/11 MUN FP Academic Half Day 221

    L Dopa Fairly Effective in Eliminating Most ofthe Symptoms of Parkinson Disease

    Bradykinesia and Rigidity Quickly Respond toL Dopa

    Reduction in Tremor Effect with ContinuedTherapy

    L Dopa less Effective in Eliminating PosturalInstability and Shuffling Gait Meaning Other

    Neurotransmitters Are Involved in ParkinsonDisease

    Long Term Therapy

    Behavioral Disturbances in 20 to 25% of Population

  • 8/6/2019 cns diseases1

    222/304

    11/07/11 MUN FP Academic Half Day 222

    Trouble in Thinking (Cognitive Effects) L Dopa Can Induce:

    Psychosis

    Confusion

    Hallucination Anxiety

    Delusion

    Some Individuals develop Hypomania Which IsInappropriate Sexual Behavior; "Dirty Old Man",

    "Flashers"

    "On/off" Effect

  • 8/6/2019 cns diseases1

    223/304

    11/07/11 MUN FP Academic Half Day 223

    "On/off" Effect Is like a Light Switch ; WithoutWarning, All of a Sudden, Person Goes fromFull Control to Complete Reversion Back toBradykinesia, Tremor, Etc. Lasting from 30Minutes to Several Hours and Then Get Control

    Again "On/off" Effect Occurs after usually after 2 or

    more years on L Dopa

    Related to Denervation Hypersensitivity

  • 8/6/2019 cns diseases1

    224/304

    Bromocriptine

  • 8/6/2019 cns diseases1

    225/304

    11/07/11 MUN FP Academic Half Day 225

    For Treating Parkinson Disease ; anErgotamine derivative, acts as aDopamine Receptor Agonist theDrug Produces Little Response inPatients That Do Not React toLevodopa

  • 8/6/2019 cns diseases1

    226/304

    11/07/11 MUN FP Academic Half Day 226

    Pramipexole

    Pramipexole

  • 8/6/2019 cns diseases1

    227/304

    11/07/11 MUN FP Academic Half Day 227

    Pramipexole is a nonergot dopamine agonistwith high relative in vitrospecificity and fullintrinsicactivity at the D

    2subfamily of dopamine

    receptors, binding with higher affinity to D3than

    to D2 or D4receptor subtypes.

    Precise mechanism ofaction is unknown,although it is believed to be related to its abilityto stimulate dopamine receptors in the striatum.

    Amantadine

    http://defwindow%28%27agonist%27%29/http://defwindow%28%27specificity%27%29/http://defwindow%28%27intrinsic%27%29/http://defwindow%28%27activity%27%29/http://defwindow%28%27affinity%27%29/http://defwindow%28%27receptor%27%29/http://defwindow%28%27mechanism%27%29/http://defwindow%28%27action%27%29/http://defwindow%28%27stimulate%27%29/http://defwindow%28%27stimulate%27%29/http://defwindow%28%27action%27%29/http://defwindow%28%27mechanism%27%29/http://defwindow%28%27receptor%27%29/http://defwindow%28%27affinity%27%29/http://defwindow%28%27activity%27%29/http://defwindow%28%27intrinsic%27%29/http://defwindow%28%27specificity%27%29/http://defwindow%28%27agonist%27%29/
  • 8/6/2019 cns diseases1

    228/304

    11/07/11 MUN FP Academic Half Day 228

    Amantadine for Treating ParkinsonDisease

    Amantadine Effective as in theTreatment of Influenza, however hassignificant Antiparkinson Action; itappears to Enhance Synthesis,Release, or Reuptake of Dopamine

    from the Surviving Nigral Neurons

    Deprenyl ( Selegiline)

  • 8/6/2019 cns diseases1

    229/304

    11/07/11 MUN FP Academic Half Day 229

    Deprenyl ( Selegiline) for TreatingParkinson Disease

    Deprenyl Selectively InhibitsMonoamine Oxidase B WhichMetabolizes Dopamine, but Does NotInhibit Monoamine Oxidase a WhichMetabolizes Norepinephrine and

    Serotonin

    The Protective Effects of Selegiline

  • 8/6/2019 cns diseases1

    230/304

    11/07/11 MUN FP Academic Half Day 230

    Although the factors responsible for the loss of

    nigrostriatal dopaminergic neurons in Parkinson's

    disease are not understood, the findings from

    neurochemical studies have suggested that thesurviving striatal dopamine neurons accelerate the

    synthesis of dopamine, thus enhancing the

    formation of H202 according to the following

    scheme.

    Amphetamine for Treating Parkinson

    Disease

  • 8/6/2019 cns diseases1

    231/304

    11/07/11 MUN FP Academic Half Day 231

    Amphetamine Has Been UsedAdjunctively in the Treatment ofSome Parkinsonian Patients it IsThought That, by ReleasingDopamine and Norepinephrine fromStorage Granules, AmphetamineMakes Patients More Mobile and

    More Motivated

    Catechol-O-methyltransferase (COMT)

    inhibitors

  • 8/6/2019 cns diseases1

    232/304

    11/07/11 MUN FP Academic Half Day 232

    Tolcapone (Tasmar) and Entacapone (Comtan) aretwo well-studied COMT inhibitors.

    Increases the duration of effect of levodopa dose

    Can increase peak levels of levodopa

    Should be taken with carbidopa/levodopa (not effective

    used alone) Can be most beneficial in treating "wearing off" responses

    Can reduce carbidopa/levodopa dose by 20-30%

    Antimuscarinic Agents for Treating

    Parkinson Disease

  • 8/6/2019 cns diseases1

    233/304

    11/07/11 MUN FP Academic Half Day 233

    The Antimuscarinic Agents Are Muchless Efficacious than Levodopa, andThese Drugs Play Only an AdjuvantRole in Antiparkinson Therapy theActions of Atropine, Scopolamine,Benztropine, Trihexyphenidyl, andBiperiden Are Similar

    On the Horizon A number of potential Parkinson's treatments in research laboratories

    now show much promise. They include:

  • 8/6/2019 cns diseases1

    234/304

    11/07/11 MUN FP Academic Half Day 234

    Neurotrophic proteins--These appear to protect nerve cells fromthe premature death that prompts Parkinson's. One hurdle isgetting the proteins past the blood-brain barrier.

    Neuroprotective agents--Researchers are examining naturallyoccurring enzymes that appear to deactivate "free radicals,"chemicals some scientists think may be linked to the damage doneto nerve cells in Parkinson's and other neurological disorders.

    Spinal Cord TractsSpinal Cord Tracts

    Spinal Cord TractsSpinal Cord Tracts

  • 8/6/2019 cns diseases1

    235/304

    11/07/11 MUN FP Academic Half Day

    Ascending TractsAscendingTracts

    Posterior White Column-Medial Lemniscal PathwayPosterior White Column-Medial Lemniscal Pathway

    Spinothalamic TractSpinothalamic Tract

    Spinoreticular or Spinoreticulothalamic TractSpinoreticular or Spinoreticulothalamic Tract

    Spinocerebellar TractSpinocerebellar Tract

    Spinomedullothalamic TractSpinomedullothalamic Tract

    Cervicothalamic or Spinocervicothalamic TractCervicothalamic or Spinocervicothalamic TractSpino-olivary TractSpino-olivary Tract

    Spinotectal TractSpinotectal Tract

    Ascending TractsAscendingTracts

    Posterior White Column-Medial Lemniscal PathwayPosterior White Column-Medial Lemniscal Pathway

    Spinothalamic TractSpinothalamic Tract

    Spinoreticular or Spinoreticulothalamic TractSpinoreticular or Spinoreticulothalamic Tract

    Spinocerebellar TractSpinocerebellar Tract

    Spinomedullothalamic TractSpinomedullothalamic Tract

    Cervicothalamic or Spinocervicothalamic TractCervicothalamic or Spinocervicothalamic Tract

    Spino-olivary TractSpino-olivary Tract

    Spinotectal TractSpinotectal Tract

    Descending Tracts from Brain StemDescending

    Tracts from Brain Stem

    Descending Tracts from Brain StemDescending

    Tracts from Brain Stem

    Spinal Cord Descending TractsSpinal Cord Descending Tracts

    Spinal Cord Descending TractsSpinal Cord Descending Tracts

  • 8/6/2019 cns diseases1

    236/304

    11/07/11 MUN FP Academic Half Day

    Dorsolateral (Motor) PathwayDorsolateral (Motor) Pathway

    Rubrospinal TractRubrospinal Tract

    Ventromedial (Motor) PathwayVentromedial (Motor) Pathway

    Tectospinal TractTectospinal TractVestibulospinal TractVestibulospinal Tract

    MLF (Medial Longitudinal Fasciculus)MLF (Medial Longitudinal Fasciculus)

    - interstitiospinal tract- interstitiospinal tract

    Sensory Modulation pathwaysSensory Modulation pathwaysRaphespinal & Cerulospinal PathwaysRaphespinal & Cerulospinal Pathways

    Descending Autonomic PathwaysDescending Autonomic Pathways

    Dorsolateral (Motor) PathwayDorsolateral (Motor) Pathway

    Rubrospinal TractRubrospinal Tract

    Ventromedial (Motor) PathwayVentromedial (Motor) Pathway

    Tectospinal TractTectospinal TractVestibulospinal TractVestibulospinal Tract

    MLF (Medial Longitudinal Fasciculus)MLF (Medial Longitudinal Fasciculus)

    - interstitiospinal tract- interstitiospinal tract

    Sensory Modulation pathwaysSensory Modulation pathwaysRaphespinal & Cerulospinal PathwaysRaphespinal & Cerulospinal Pathways

    Descending Autonomic PathwaysDescending Autonomic Pathways

    Upper Motor Neuron (UMN) vs. Lower Motor Neuron (LMN) SyndromeUpper Motor Neuron (UMN) vs. Lower Motor Neuron (LMN) Syndrome

    UMN syndromeUMN syndrome LMN SyndromeLMN Syndrome

  • 8/6/2019 cns diseases1

    237/304

    11/07/11 MUN FP Academic Half Day

    Type of ParalysisType of Paralysis Spastic ParesisSpastic Paresis Flaccid ParalysisFlaccid Paralysis

    AtrophyAtrophy No (Disuse) AtrophyNo (Disuse) Atrophy SevereSevereAtrophyAtrophy

    Deep Tendon ReflexDeep Tendon Reflex IncreaseIncrease Absent DTRAbsent DTR

    Pathological ReflexPathological Reflex PositivePositive BabinskiBabinskiSignSign AbsentAbsent

    Superficial ReflexSuperficial Reflex AbsentAbsent PresentPresent

    Fasciculation andFasciculation and AbsentAbsent Could beCould be

    FibrillationFibrillation PresentPresent

    Spinal Cord SyndromeSpinal Cord Syndrome

    Spinal Cord SyndromeSpinal Cord Syndrome

  • 8/6/2019 cns diseases1

    238/304

    11/07/11 MUN FP Academic Half Day

    Predominantly Motor SyndromesPredominantlyMotor Syndromes

    Poliomyelitis (Infantile Paralysis)Poliomyelitis (Infantile Paralysis)

    - viral infection of lower motor neuron- viral infection of lower motor neuron

    - LMN syndrome at the level of lesion- LMN syndrome at the level of lesion

    Amyotrophic Lateral Sclerosis (ALS)Amyotrophic Lateral Sclerosis (ALS)

    - combined LMN and UMN lesion- combined LMN and UMN lesion

    - LMN syndrome at the level of lesion- LMN syndrome at the level of lesion

    - UMN syndrome below the level of lesion- UMN syndrome below the level of lesion

    - Lou Gehrigs disease- Lou Gehrigs disease

    Spinal Cord SyndromeSpinal Cord Syndrome

    Spinal Cord SyndromeSpinal Cord Syndrome

    Predominantly

    Sensory Syndromes

  • 8/6/2019 cns diseases1

    239/304

    11/07/11 MUN FP Academic Half Day

    Predominantly Sensory Syndromesy y y

    Herpes ZosterHerpes Zoster

    - inflammatory reactions of spinal ganglion- inflammatory reactions of spinal ganglion

    - severe pain on the dermatomes of affected ganglion- severe pain on the dermatomes of affected ganglion

    Tabes DorsalisTabes Dorsalis- common variety of neurosyphilis- common variety of neurosyphilis

    - posterior column and spinal posterior root lesion- posterior column and spinal posterior root lesion

    - loss of discriminative touch sensation and conscious- loss of discriminative touch sensation and consciousproprioception below the level of lesionproprioception below the level of lesion

    - posterior column ataxia- posterior column ataxia

    - lancinating pain (- lancinating pain (a stabbing or piercing sensationa stabbing or piercing sensation))

    - loss of deep tendon reflex (DTR)- loss of deep tendon reflex (DTR)

    Spinal Cord SyndromeSpinal Cord Syndrome

    Spinal Cord SyndromeSpinal Cord Syndrome

  • 8/6/2019 cns diseases1

    240/304

    11/07/11 MUN FP Academic Half Day

    Sub-Acute Combined DegenerationSub-Acute Combined Degeneration

    (Combined System Disease)(Combined System Disease)

    LesionLesion

    - posterior white column- posterior white column- corticospinal tract (UMN)- corticospinal tract (UMN)

    SymptomSymptom

    - loss of discriminative touch sensation and conscious- loss of discriminative touch sensation and conscious

    proprioception below the level of lesionproprioception below the level of lesion- ipsilateral UMN syndrome below the level of lesion- ipsilateral UMN syndrome below the level of lesion

    Spinal Cord SyndromeSpinal Cord Syndrome

    Spinal Cord SyndromeSpinal Cord Syndrome

  • 8/6/2019 cns diseases1

    241/304

    11/07/11 MUN FP Academic Half Day

    Syringomyelia, HematomyeliaSyringomyelia, HematomyeliaLesionLesion

    - central canal of spinal cord- central canal of spinal cord

    - gradually extended to peripheral part of the cord- gradually extended to peripheral part of the cord

    SymptomSymptom

    - initial symptom is bilateral loss of pain- initial symptom is bilateral loss of pain

    (compression of anterior white commissure)(compression of anterior white commissure)

    - variety of symptoms appear- variety of symptoms appearaccording to the lesion extended from central canalaccording to the lesion extended from central canal

  • 8/6/2019 cns diseases1

    242/304

    Interferon Beta 1a (Avonexand Rebif):

  • 8/6/2019 cns diseases1

    243/304

    11/07/11 MUN FP Academic Half Day 243

    Is a protein that is a replica of humaninterferon. It suppress the immune system and

    helps to maintain the blood-brainbarrier.

    You inject Avonex into the muscle oncea week and Rebif is injected under theskin three times a week. This drug isuseful to people who have definiteprogressive MS.

    One side effect of the drug is a flu likesymptom.

    Courses of MSCourses of MS

  • 8/6/2019 cns diseases1

    244/304

    11/07/11 MUN FP Academic Half Day 244

    Relapse-remitting MS (RRMS):

    h k

  • 8/6/2019 cns diseases1

    245/304

    11/07/11 MUN FP Academic Half Day 245

    Here have an attack, go intocomplete or partial remission, thenhave the symptoms return.

    Primary-progressive MS (PPMS):

    H i ll d li d h

  • 8/6/2019 cns diseases1

    246/304

    11/07/11 MUN FP Academic Half Day 246

    Here continually decline and have noremissions.

    There may be a temporary relief insymptoms.

    A few patients have malignant MSwhich is where they have a quickdecline which leaves them severely

    disabled or even lead to death.

    Secondary-progressive MS (SPMS):

    Thi f MS i h RRMS

  • 8/6/2019 cns diseases1

    247/304

    11/07/11 MUN FP Academic Half Day 247

    This stage of MS starts with RRMSsymptoms and continues on toshow signs of PPMS.

    Progressive-relapsing MS (PRMS):

    Thi i f b t h it t k